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Abstract
DNA damage contributes to the process of aging, as underscored by premature aging syn-
dromes caused by defective DNA repair. Thyroid state changes during aging, but underly-
ing mechanisms remain elusive. Since thyroid hormone (TH) is a key regulator of
metabolism, changes in TH signaling have widespread effects. Here, we reveal a significant
common transcriptomic signature in livers from hypothyroid mice, DNA repair-deficient mice
with severe (Csbm/m/Xpa-/-) or intermediate (Ercc1-/Δ-7) progeria and naturally aged mice. A
strong induction of TH-inactivating deiodinase D3 and decrease of TH-activating D1 activi-
ties are observed in Csbm/m/Xpa-/- livers. Similar findings are noticed in Ercc1-/Δ-7, in natu-
rally aged animals and in wild-type mice exposed to a chronic subtoxic dose of DNA-
damaging agents. In contrast, TH signaling in muscle, heart and brain appears unaltered.
These data show a strong suppression of TH signaling in specific peripheral organs in pre-
mature and normal aging, probably lowering metabolism, while other tissues appear to pre-
serve metabolism. D3-mediated TH inactivation is unexpected, given its expression mainly
in fetal tissues. Our studies highlight the importance of DNA damage as the underlying
mechanism of changes in thyroid state. Tissue-specific regulation of deiodinase activities,
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Introduction
Aging is a complex and still poorly understood process although damage to macromolecules is
considered to be an important contributing factor. Particularly, damage to nuclear DNA,
which carries the blueprint of life, can exert harmful, widespread and lasting effects on cell
function, viability and growth. A causative role of DNA damage in aging is unequivocally dem-
onstrated by the identification of genetic defects in DNA repair in a large fraction of progeroid
syndromes [1]. A major route of DNA repair is nucleotide excision repair (NER), a multi-step
“cut-and-patch” repair mechanism which is responsible for removing a remarkable diversity of
helix-distorting lesions caused by exogenous factors or endogenous metabolism, thus integrat-
ing environmental and intrinsic contributions to the aging process.
Important insights into the link between DNA damage and aging have come from studies
using rapidly aging mice with defects in transcription-coupled NER (TC-NER) as models for
human progeroid syndromes [2–4]. In the absence of TC-NER, the vital process of transcrip-
tion is hampered by persisting DNA lesions, causing accelerated cell death and thus premature
aging. Since progeroid mutants display varying extents of accelerated aging in different tissues,
presumably reflecting tissue-dependent induction of DNA damage, expression of repair and/or
damage response genes they are termed ‘segmental’ progeroid syndromes. Nevertheless,
TC-NER deficient patients and corresponding mouse mutants are valuable models that mani-
fest many genuine aspects of normal aging in an accelerated manner [5–7].
The stochastic accumulation of DNA damage appears to contrast the prominent genetic
component also identified in the process of aging. Mutations in specific endocrine signaling
pathways, specifically those suppressing the growth hormone/insulin-like growth factor 1
(GH/IGF1) axis, markedly prolong lifespan in numerous organisms including mammals [8],
whereas conversely over-expression of GH in transgenic mice accelerates many features of
aging and reduces life expectancy [9].
This paradox of genetic regulation of longevity versus stochastic damage accumulation was
reconciled by studies in progeroid repair mouse mutants [3,4,10]. Genome-wide expression
profiles in livers of progeroid and naturally aging mice showed marked similarities, indicating
the relevance of progeroid models for normal aging. Interestingly, a suppressed GH/IGF1 axis
and concomitantly up-regulated anti-oxidant defenses were observed in short-lived repair
mutants, long-lived mice (dwarf mutants with pituitary dysfunction), in normal mice upon
chronic non-toxic exposure to DNA-damaging agents, as well as in cultured cells after induc-
tion of persisting DNA damage. A similar response is also reported during dietary restriction
and in naturally aged mice [3,4, 11], indicating its universal nature. Therefore, the paradox of
somatotroph axis suppression in long-lived as well as short-lived animals indicates that this
response to accumulating DNA damage represents an attempt to lower metabolism and boost
defenses, entailing a shift from growth and development to a preservation mode, which intends
to promote lifespan extension [12]. In a wider perspective, suppression of the GH/IGF1 axis
which is observed in stressful situations (e.g. food shortage, severe illness) may be regarded as
an adaptive ‘survival’ response which transiently prioritizes defense systems at the expense of
growth. Because of chronic stress a similar response may become constitutively induced in
later stages of the aging process [12].
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Since thyroid hormone (TH) is one of the few known genuine stimulators of metabolic rate,
changes in TH metabolism and action have widespread effects on the function of organisms
ranging from small non-vertebrates to humans. TH is crucial for development and metabolism
of virtually all tissues. TH action involves the production of the prohormone T4 by the thyroid
gland and its conversion to bioactive T3 in peripheral tissues by the deiodinases D1 and D2.
The deiodinase D3 degrades T4 and T3 to receptor-inactive metabolites [13]. Time- and tis-
sue-specific expression of the different deiodinases ensures a coordinated spatiotemporal con-
trol of intracellular TH concentrations [13]. Although non-genomic actions have been
reported, the biological actions of TH are largely mediated by binding of T3 to nuclear recep-
tors (T3-receptors; TRs), thus modulating the expression of TH target genes. Changes in thy-
roid state which are associated with aging are likely to have important consequences. For
example, dwarf mice with pituitary hormone deficiencies resulting in low GH/IGF1 and TH
levels have a prolonged lifespan, and life-long T4 substitution of those animals markedly short-
ens their lifespan [14–16], suggesting a strong connection of TH with lifespan regulation.
Currently, the molecular mechanisms underlying changes in thyroid state during aging are
unknown. Furthermore, it is still elusive if DNA damage contributes to the age-related changes
in TH homeostasis and if changes in TH signaling are maladaptive or represent a beneficial
response.
Here, we studied TH signaling with a focus on deiodinase regulation in different NER-defi-
cient mice including Csbm/m/Xpa-/- double mutant mice with extremely accelerated aging (XAA;
lifespan 3–5 weeks) and Ercc1-/Δ-7mice with moderately accelerated aging (MAA; lifespan 4–6
months), and also naturally aging wild-type (WT) mice. We observed that TH signaling is sup-
pressed in accelerated and normal aging. Interestingly, we noticed a dramatic reactivation of the
TH-inactivating enzyme D3 in the liver, which is normally mainly expressed in embryonic tis-
sues. Also, studies in animals with an interrupted GH/IGF1 axis (without defects in DNA dam-
age repair) suggest that the D3 induction is independent of the somatotrophic axis. WT mice
treated with the pro-oxidant bis(2-ethylhexyl)phthalate (DEHP) also display induction of D3
and suppression of TH signaling. The present findings disclose a novel link between DNA dam-
age, compromised genome maintenance, and TH homeostasis through deiodination. We
hypothesize that adaptation of TH signaling has a net beneficial impact on aging.
Materials and Methods
Animals
The generation and characterization of NER-deficient Csbm/m/Xpa-/- and Ercc1-/Δ-7 mice has
been previously described [4,17]. With the exception of Ercc1-/Δ-7 mice which were generated
in a genetically uniform FVB:C57BL/6J (50:50) F1 hybrid genetic background, all mice were
bred in a pure C57BL/6J genetic background. Animals were kept on a regular diet and housed
at the Animal Resource Center (Erasmus University Medical Center) and the National Institute
of Public Health and the Environment (RIVM), which operate in compliance with the “Animal
Welfare Act” of the Dutch government, using the “Guide for the Care and Use of Laboratory
Animals” as its standard. Csbm/m/Xpa-/- and Ercc1-/Δ-7 mice have a lifespan of 3–4 and 22–28
weeks respectively. As required by Dutch law, formal permission to generate and use geneti-
cally modified animals was obtained from the responsible local and national authorities. All
animal studies were approved by the Animal Ethical Committee of the Erasmus University
Medical Center (Dutch equivalent of the IACUC). The generation and characterization of
transgenic mice overexpressing bovine growth hormone (bGH TGmice) have been previously
reported [18]. Mice deficient in the GH receptor (Ghr KO) have been described before [19]. All
experiments were conducted in accordance with NIH and local animal care guidelines. Studies
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were done with mice from both sexes, except for the naturally aged mice (only males) and the
DEHP-treated mice (only females). Animals were sacrificed by cervical dislocation.
Microarray analysis
Independent datasets on liver samples were collected from previous studies [4,20]: 15-day-old
Csbm/m/Xpa-/- (n = 3), 16-week old Ercc1-/Δ-7 (n = 3), and age-matched WT controls (n = 3),
13-week old and 130-week old mice (n = 3) (E-MEXP-835, E-MEXP-1503 and E-MEXP-1504
all based on Affymetrix Mouse Genome 430 2.0 arrays) and euthyroid and hypothyroid WT
mice (n = 3) (GSE10001, based on Affymetrix Mouse Gene 1.0 ST arrays). CEL files from these
experiments were processed independently using the Partek software and differential expres-
sion values and corresponding p-values were obtained using ANOVA. Since the type of arrays
used in these studies were different, they were matched by their corresponding RefSeq tran-
scripts IDs (18440 matches in total) using home-made programs (Python™). The data was then
filtered based on thresholds of1.2-fold change (up and down) and p-values0.05.
Venn diagrams were produced using the Venny online tool (http://bioinfogp.cnb.csic.es/
tools/venny/index.html) [21]. Significance of the overrepresentation of common and co-direc-
tionally regulated genes was approximated using Poisson and binomial distributions.
To analyze for gene expression similarities, we subsequently filtered out genes that were not
present in all four data sets. These groups were subsequently clustered based on co-directional-
ity of expression changes and heatmaps were constructed using the MultiExperimentViewer
software.
All gene lists were also analysed using the Ingenuity Pathway Analysis software to look for
dataset significant enrichment for specific pathways.
Histology
Thyroid glands from 15-day-old Csbm/m/Xpa-/- (n = 4), 16-week old Ercc1-/Δ-7 (n = 4) and age-
matched WT controls (n = 4) were fixed in formalin and embedded in paraffin, sectioned and
stained with haematoxylin/eosin (H&E). All samples were examined blindly.
Serum and tissue T4 and T3 concentrations
Serum T4 and T3 levels were determined by radioimmunoassay (within- and between assay
variability 2–8% and 5–10% for T4 and 2–6% and 8% for T3) as previously described [22].
Briefly, 125I-labeled iodothyronines were obtained from Amersham Pharmacia Biotech. T4
antiserum was obtained from Sigma-Aldrich (St. Louis, MO), and T3 antiserum was produced
in the Rotterdam laboratory. Final antibody dilutions were 1:20,000 for T4 and 1:250,000 for
T3. The sample volume was 10 μl for T4, 20 μl for T3, and incubation mixtures were prepared
in 0.5 ml RIA buffer. Mixtures were incubated in duplicate overnight at 4 C, and antibody-
bound radioactivity was precipitated using Sac-Cel cellulose-coupled second antibody (IDS,
Boldon, UK). Tissue T4 and T3 content was measured by radioimmunoassay after extraction,
as previously described [23]. Briefly, RIAs were used for the determination of T4 and T3 in tis-
sues but prior to the RIA the THs were extracted. The sample was ho- mogenized directly in
methanol, and [131I]T4 and [125I]T3 were added to each sample as internal tracers for recov-
ery calculations. These tracers were added in amounts small enough to avoid interferences in
the final RIAs. Appropriate volumes of chloroform were added to extract with chloroform/
methanol (2:1), twice. The iodothyronines were then back-extracted into an aqueous phase
and purified by passing this aqueous phase through Bio-Rad AG 1x2 resin columns. After a pH
gradient, the iodothyronines were eluted with 70% acetic acid, which was then evaporated to
dryness and the residue dissolved in RIA buffer. Each extract was extensively counted to
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determine the recovery of the [131I]T4 and [125I]T3 added to each sample during the initial
homogenization process. Concentrations were then calculated using the amounts of T4 and T3
found in the respective RlAs, the individual recovery of the [131I]T4 and [125I]T3 added to
each sample during the initial homogenization process, and the weight of the tissue sample
submitted to extraction. The results are given throughout in picomoles per gram wet weight.
Serum TSH levels were determined as described previously [24].
Deiodinase activities
The activities of the deiodinases D1, D2 and D3 were measured as reported previously [25].
Briefly, tissues were homogenized in 10 vol 0.1 M phosphate (pH 7.2), 2 mm EDTA, and 1 mm
dithiothreitol (P100E2D1 buffer). Aliquots of homogenates were snap-frozen and stored at −80
C until analysis of enzyme activities. Deiodinase activities were assayed by monitoring the pre-
ferred reaction catalyzed by the different isoenzymes, i.e. ORD of rT3 by D1, ORD of T4 by D2,
and IRD of T3 by D3. D1 and D2 activities were assayed by measurement of the release of radio-
iodide from outer ring-labeled substrates, and D3 activity was assayed by HPLC analysis of the
formation of radioactive 3,30-T2 and 30-iodothyronine (30-T1) from outer ring-labeled T3.
Oxidative stress
To investigate oxidative stress, 10-week old WT animals were exposed through food to the
non-carcinogenic dose of 6000 ppm DEHP daily for a period of 2, 12 or 39 weeks.
qRT-PCR
cDNA was synthesized using 1 μg RNA and Superscript™IIReverse Transcriptase (Life Tech-
nologies, Breda, The Netherlands). SYBR Green I (Eurogentec, Maastricht, The Netherlands)
was used as detector dye for qRT-PCR of the Abca3, Abcc3, Cs, Fmo3, Elolv3, Cbr1, Cs, G6pc,
Mup2, Nudt7, Prodh, Slc22a7, Stat5b, Thrsp (Spot14), Dio1, Dio3, Serca1, Serca2, Ucp3, Slc2a4,
Glut4,Hcn2,Myh6 (MHC-α),Myh7 (MHC-β), Mct8, Mct10, Ntcp, Lat1, Lat2, Oatp1a1,
Oatp1a4, Oatp1b2, Thra and Thrb. genes. Primer sequences are provided in S1 Table. The
housekeeping genes B2M, RPS9 and tubulin were used for normalization.
Results
Gene expression changes indicate suppression of TH signaling
To determine if TH signaling is altered during aging in our mouse mutants, we assessed thyroid
state in livers of extremely aging (XAA; abbreviation for Csbm/m/Xpa-/- KOmice), moderately
aging (MAA; abbreviation for Ercc1-/Δ-7 KOmice) and naturally old WT mice. First, we
explored if livers of progeroid mice are hypothyroid by measuring expression levels of classic
T3-responsive genes. To this aim, we quantified Dio1 and ThrspmRNA levels, highly sensitive
markers of hepatic thyroid state. Expression of both genes was significantly (~3 to 30-fold)
decreased in livers of 18-day old XAA mice and 16-week old MAA mice compared to age-
matched controls, strongly suggesting that livers of these progeroid mutants are in a hypothy-
roid state (Fig 1A and 1B).
To obtain a complete overview, we explored if TH-dependent transcriptional programs are
altered during aging by genome-wide expression profiling. To this aim we first determined the
effect of thyroid state on the liver mRNA expression profile by comparing livers from young
adult (9-week old) euthyroid WT mice and WTmice rendered hypothyroid using a low iodine
diet supplemented with propylthiouracil [26]. Using predefined criteria, we filtered out a set of
6897 genes which is differentially expressed under hypothyroid conditions (data not shown).
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Fig 1. Gene expression changes in livers from progeroid and normal agingmice.Gene expression of the T3-responsive genes Dio1 and Thrsp in
18-day-old XAA (Csbm/m/Xpa-/-) (A) and 16-week-old MAA (Ercc1-/Δ-7) mice (B). * P < 0.005; # P = 0.12. Expression profiling of a set of known
T3-responsive genes in 15-day-old XAA (Csbm/m/Xpa-/-) (C) and 16-week-old MAA (Ercc1-/Δ-7) mice (D) mutants compared to age-matched controls.
Values represent mean ± SE * P < 0.05; ** P < 0.005; $ P < 0.1; # P = 0.12.
doi:10.1371/journal.pone.0149941.g001
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PLOS ONE | DOI:10.1371/journal.pone.0149941 March 8, 2016 6 / 25
In the same way, we compared the microarray datasets of liver samples from 15-day old XAA
mice or 16-week old MAA mutants with age-matched WT animals, and from 130-week versus
13-week old WT mice, resulting in 3005, 3559 and 2536 differentially expressed genes, respec-
tively. Spearman’s rank correlation coefficients indicate strong similarities between progeroid
mutants and naturally aging mice, further supporting the validity of the progeroid models for
normal aging ([20] and data not shown). The overlap of differentially expressed transcripts
among the various models versus their corresponding controls is represented by a Venn dia-
gram in S1 Fig.
Then, using the list of genes differentially expressed in hypothyroid animals, we asked if
there is overlap with the 364 differentially expressed genes common to the naturally aging mice
and prematurely aging models. Among these 364 age-related genes, 160 showed a significant
change in expression in hypothyroid livers (p<0.021, S1 Fig). Approximately 2/3 of these genes
displayed a change in the same direction in both hypothyroid and aging profiles (S1 Fig,
p<0.0001). The set of 160 genes overlapping between hypothyroid and aging mice is presented
in S2 Table. It should be realized that the hypothyroid animals were exposed to a low iodine
diet supplemented with propylthiouracil which may elicit a response by itself. Hence, in view
of the difference in treatment and biological age it is striking that the majority of genes dis-
played a similar directional change.
Pathway analysis revealed a series of shared biological processes which are over-represented
among the differentially expressed genes (up and down) common to hypothyroid and aging
mouse models (S2 Fig). This includes a strong representation of the RAR, PPAR/RXR/TR and
PI3K/AKT, PTEN signaling systems as well as the ERK/MAPK and other signaling pathways,
various cancer-related mechanisms (particularly in the hypothyroid and naturally aging pro-
files), and components of inflammatory processes. Also the profiles list the involvement of the
NRF2-controlled anti-oxidant system and P53 signaling pointing to a link with DNA damage
and oxidative stress. Although anticipated, the significant over-representation of the TR/RXR
pathway supports the idea of altered TH signaling during both normal and accelerated aging.
As a complementary approach, we measured expression levels of known T3-responsive
genes using qRT-PCR. This set of 15 genes was compiled from different independent studies
investigating the effect of T3 on the mouse liver transcriptome [27–30]. Indeed, most
T3-responsive genes were changed in livers of 15-day-old XAA mice and even more pro-
nounced in 16-week old MAA mice (Fig 1C and 1D). This agrees with the regulation of this set
of genes in normally and prematurely aging animals although less pronounced (S3 Fig).
Indeed, using qRT-PCR, we observed a trend in reduction in many of these genes, although it
failed to reach statistical significance (S3 Fig).
Altogether, gene expression analysis of livers of normally and prematurely aging mice
revealed marked similarities with hypothyroid livers, indicating a suppression of TH signaling.
These findings support the link between DNA damage, aging and altered TH signaling.
Thyroid gland histology and serum T4 and T3 concentrations
To investigate the origin of the reduced TH signaling in liver of normally and prematurely
aging mice, we first measured serum TH concentrations over time. Significantly lower serum
T4 and T3 levels were observed in XAA mice compared to WT controls at all ages examined
(Fig 2A and 2B). The differences were already detectable at day 7 and most pronounced at days
12 and 15. The postnatal increase in serum T4 and T3 levels of WT animals, peaking at day 15,
perfectly replicated previous findings [22]. Remarkably, although the gene expression profiles
of both progeroid mutants suggested an altered thyroid state, serum TH levels did not differ
between MAAmice and their normal littermates, at least at the 4 and 18 week time points
Tissue-Specific Suppression of Thyroid Hormone Signaling during Aging
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Fig 2. Thyroid state in serum of progeroid and naturally agedmice. Serum T4 (A) and T3 (B) concentrations in 7-, 12-, 15-, and 18-day-old WT (squares)
and XAA (Csbm/m/Xpa-/-) mice (circles) (n = 3/group). Serum T4 (C) and T3 (D) concentrations in 4-, and 18-week-oldWT (black bars) and MAA (Ercc1-/Δ-
7) (white bars) mice (n = 3/group). Serum T4 and T3 concentrations in 26-, 104-, and 130-week-old WTmale mice (n = 3-4/group) (E). Serum TSH levels in
15-day old WT and XAA (Csbm/m/Xpa-/-) mice (F) and in 26-, 104-, and 130-week-old WTmale mice (G). Values represent mean ± SE per group. * P < 0.05;
** P < 0.01; *** P < 0.001; # P = 0.054.
doi:10.1371/journal.pone.0149941.g002
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analysed (Fig 2C and 2D). In addition, no decrease in serum TH concentrations was observed
with advancing age in WT animals (Fig 2E). TSH levels were normal in XAA (Fig 2F) and
MAAmutants (S4 Fig). A slight increase in TSH levels was noted in 130-week old WT mice
(Fig 2G).
Macroscopic inspection and histological analysis of the thyroid glands did not reveal obvi-
ous abnormalities in XAA (Fig 3A) and MAA (Fig 3B) mice. Together, these data suggest that
peripheral TH metabolism is altered rather than primary dysfunction of the thyroid gland or
pituitary.
Thyroid state in liver and kidney
It is increasingly recognized that local TH concentrations do not necessarily parallel serum TH
levels but that tissue TH levels are modulated by deiodinases and transporters [13,31]. There-
fore, we determined tissue levels of T4 and T3 in the different mouse models. At all ages tested,
hepatic TH levels were lower in XAA mice than in WT mice, although the differences were
clearly greater for T3 than for T4 (Fig 4A and 4B). This was reflected in a markedly decreased
T3/T4 ratio (0.059± 0.004 in XAA mice vs. 0.10±0.01 in WT mice; P<0.05). We evaluated the
effects of the decreased TH state in liver on D1 activity, which catalyzes T4 to T3 conversion
but is also positively controlled by T3. As anticipated, D1 activity increased from postnatal day
5 to 18 in WTmice but much less so XAA mice (Fig 4C).
Since D3 activity may also affect local TH availability, we investigated if the larger decrease
in liver T3 than in serum T3 levels is explained by an increased D3 activity. Interestingly, a
large induction of D3 activity was observed in XAA mice (Fig 4D). D3 activity was already
stimulated at day 12, preceding the drop in liver T3 content at day 15, suggesting that the
Fig 3. Histological examination of haematoxylin/eosin-stained thyroid glands of 15-day-old WT and
XAA (Csbm/m/Xpa-/-) (A) and 16-week-old WT and MAA (Ercc1-/Δ-7) (B) mice (all magnifications 10x).
The thyroid follicles (denoted by asterisk) surrounded by thyrocytes (denoted by arrow) are similar between
WT and progeria models.
doi:10.1371/journal.pone.0149941.g003
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Fig 4. Thyroid state in liver of progeroid and naturally agedmice. T4 (A) and T3 (B) concentrations in livers of 7-, 12-, 15-, and 18-day-old WT (squares)
and XAA (Csbm/m/Xpa-/-) (circles) mice (n = 3/group; each time point of Csbm/m/Xpa-/- mice represents pooled tissues). Activities of D1 (C) and D3 (D) in
livers of 7-, 12-, 15-, and 18-day-old WT and XAA (Csbm/m/Xpa-/-) mice (n = 3/group). T4 (E) and T3 (F) concentrations and D1 activity (G) in livers of 4-, and
18-week-old WT (black bars) and MAA (Ercc1-/Δ-7) (white bars) mice (n = 3/group). D3 mRNA expression in livers of 13-week-old and 130-week-old mice
(H). D1 (black bars) (I) and D3 (grey bars) (J) activities in livers of 26-, 52-, and 104-week-old WTmice (n = 5/group). Values represent mean ± SE per group.
* P < 0.05; ** P < 0.01; *** P < 0.001; # P = 0.051.
doi:10.1371/journal.pone.0149941.g004
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increased D3-mediated T3 degradation aggravates the reduced T3 concentrations. It is impor-
tant to note that XAA mice are not yet cachectic at day 15.
Similar to serum concentrations, T4 and T3 levels in liver were unaffected in MAA mice
compared to WT mice at both 4 and 18 weeks of age (Fig 4E and 4F). However, D1 activity was
strongly decreased in 18-week old MAA mice (Fig 4G). D3 activities were hardly detectable in
MAA mice and littermates (data not shown).
To investigate at which level the changes in deiodinase activities originate, we measured
mRNA levels of Dio1 and Dio3 in the progeroid models using RT-qPCR. The results suggest
that the changes in D1 and D3 activities are mainly regulated at the transcriptional level
although changes in mRNA stability are not excluded (S5 Fig).
The findings in the progeroid mice prompted us to examine deiodinase expression and
activity in aging WT animals. A dramatic induction (>30-fold) in Dio3mRNA expression was
noticed in livers from 130 weeks vs. 13 weeks old mice (Fig 4H). D3 activity was also increased
with advancing age (Fig 4I). The smaller induction of D3 activity in 104-week old mice com-
pared to Dio3mRNA in 130-week old mice suggests further increased Dio3 expression between
104 and 130 weeks of age. D1 activity showed a reciprocal decrease in aging WTmice (Fig 4J),
with a significant negative correlation between the two deiodinase activities (Spearmans’s rho –
0.51; P = 0.05).
As TH transporters and TRs are part of the TH signaling pathway, we analyzed relevant
liver TH transporters and both TR isoforms in livers of all animal models (S6 Fig). No pro-
nounced changes in transporters and receptors were observed in any of the models. Only in
MAA mice, we observed a slight decrease in Lat2 expression and a modest decrease in Thrb
expression.
Taken together, these findings provide evidence that TH signaling in livers of rapidly and
normally aging animals is reduced. As transporters and receptors were generally unaffected in
contrast with the pronounced changes in D1 and D3 activity, we further focused on changes in
deiodinase activities.
We also examined the effects of aging on TH homeostasis in the kidney. Renal T4 and T3
contents were lower in XAAmice than in age-matched WTmice, corresponding to the changes
observed in serum and liver (Fig 5A and 5B). Again, substantially lower D1 expression and
activity were observed in XAA vs. WT mice (Fig 5C and S7 Fig). However, in contrast to the
liver, D3 did not increase with age in XAA mice, although the decline noted in WTmice at 18
days was not observed in XAA mice (Fig 5D and S7 Fig), indicating a relative increase in D3
activity in the progeroid mutant. Absolute D3 activity was ~3-fold lower in kidney than in
liver, suggesting that this enzyme is less important for local TH homeostasis in kidney. These
findings agree with previous observations showing that kidney TH levels mainly depend on
concentrations in serum [22].
T4 and T3 levels in kidneys of MAA mice tended to be lower with advancing age, although
not statistically significant (Fig 5E and 5F). The decreased D1 expression and activity over time
in MAAmice is consistent with this finding (Fig 5G and S6 Fig). D3 activity was virtually unde-
tectable in MAA and WT animals at 5 and 18 weeks of age (data not shown). Renal T3 levels
decreased in old WT mice, whereas T4 levels did not change (Fig 5H and 5I). No changes in
D1 activity were observed (Fig 5J). D3 activity was not significantly increased in kidneys at 130
weeks of age like in liver (Fig 5K).
Thyroid state in heart and skeletal muscle
Given the profound changes in liver and kidney, we wondered if aging changes TH signaling in
other tissues as well, especially since TH signaling can be modulated in a tissue-specific
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Fig 5. Thyroid state in kidney of progeroid and naturally agedmice. T4 (A) and T3 (B) concentrations in kidneys of 7-, 12-, 15-, and 18-day-old WT
(squares) and XAA (Csbm/m/Xpa-/-) (circles) mice (n = 3/group; each time point of Csbm/m/Xpa-/- mice represents pooled tissues). Activities of D1 (C) and
D3 (D) kidneys of 7-, 12-, 15-, and 18-day-old WT and XAA (Csbm/m/Xpa-/-) mice (n = 3/group). T4 (E) and T3 (F) concentrations in kidneys of 4-, and
18-week-old WT (black bars) and MAA (Ercc1-/Δ-7) (white bars) mice (n = 3/group; each time point of Ercc1-/Δ-7 mice represents pooled tissues, precluding
statistical analysis). T4 (H) and T3 (I) concentrations and D1 (J) and D3 (K) activities in kidneys of 26-, 104-, and 130-week-old WTmice (n = 4-5/group).
Values represent mean ± SE per group. * P < 0.05; ** P < 0.01; *** P < 0.001; # P = 0.051.
doi:10.1371/journal.pone.0149941.g005
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manner. TH metabolism appears remarkably preserved in muscle, since TH levels and the D2
and D3 activities expressed in muscle did not differ significantly between XAA, MAA and WT
mice (Fig 6A–6G). This is in agreement with findings in normally aging mice, except for a
modest decrease in D3 activity in 130-week old mice (Fig 6H–6K). Also, expression of muscle-
specific T3-target genes did not change in normal or advanced aging (data not shown).
Cardiac T4 and T3 levels were decreased in XAA mice, although the T3 change was less
obvious (Fig 7A and 7B). This is in line with the increase in cardiac D2 activity in these
mutants, possibly in response to the lower T4 levels to ensure adequate T3 levels (Fig 7C). Car-
diac D3 activity was not different between XAA andWT mice (Fig 7D). Cardiac D2 and D3
activities were barely detectable in MAA and both young and old WT mice (data not shown).
Expression of heart-specific T3-target genes was not different between the different mouse
models of normal and accelerated aging (data not shown).
Thyroid state appears preserved in brains of progeroid mice
The decreased thyroid state in liver and kidney in premature and normal aging may be a bene-
ficial response to reduce metabolism and thus to generate less reactive (damaging) metabolic
by-products. On the other hand, reduced metabolism in brain might have an adverse impact
given the essential role of the brain in coordinating vital functions, particularly under condi-
tions of stress. Therefore, we sought to determine the thyroid state in brains of the different
models of normal and advanced aging.
Both T4 and T3 content were reduced in brains of XAA mice (Fig 8A and 8B). However, in
discordance with liver and kidney, the brain T3/T4 ratio tended to increase in the mutants
(1.35±0.19 vs. 0.86±0.09; P<0.05). Furthermore, the D2 and D3 activities expressed in brain
were similar in WT and mutant animals at most ages (Fig 8C and 8D), although D3 activity
was reduced at day 15 in XAA mice (P<0.001) in striking contrast to the liver and the kidney.
Brain T4 levels in MAA mice decreased with age, while T3 levels were maintained (Fig 8E
and 8F). In agreement with the findings in XAA mice, the brain T3/T4 ratio was increased in
MAA vs. WT mice at 18 weeks (1.78±0.27 vs. 1.00±0.10 P = 0.05). Fig 8G shows that D3 activ-
ity did not differ between MAA andWTmice.
It is known that TH effects differ among various brain regions [32]. Because we used whole
brain homogenates in the previous experiments, region-specific changes in TH signaling may
have been missed. Therefore, we analyzed the expression of several well-known T3-target
genes, such asMbp2, Reln, Bteb, Ptgds and Hr, in the hippocampus, cerebellum and cerebral
cortex of 16-week old MAA mice. Most genes were unaffected, suggesting that a euthyroid
state is maintained in the MAA mouse brain (S3 Table).
XAA mice display severe growth retardation from an early postnatal stage (S8 Fig). Liver
and kidney of WT animals show a continuous increase in weight during the first weeks of life
(S8 Fig). In contrast, liver and kidney of XAA mice failed to show significant growth, and tissue
weight was even lower at day 18 than at day 15. In contrast, absolute brain weight in XAA mice
was only slightly lower, and showed a similar growth pattern as in WT mice (S8 Fig). In fact,
brain weight relative to total body weight in XAA mice was even more than twice that in WT
animals at day 18 (S4 Table). Thus, decreased THmetabolism in liver and kidney was associ-
ated with decreased weight of these tissues, whereas preserved TH signalling in brain was asso-
ciated with relatively high brain weight.
Interaction of GH/IGF1 signaling with D3 activity
In the embryonic chicken liver, GH administration induces an acute decrease in Dio3 expres-
sion [33,34]. Since the GH/IGF1 axis is suppressed in progeroid and normally aging animals
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Fig 6. Thyroid state in skeletal muscle of progeroid and naturally agedmice. T3 concentrations (A) and activities of D2 (B) and D3 (C) in muscle of
15-day-old WT and XAA (Csbm/m/Xpa-/-) mice (n = 3/group). T4 (D) and T3 (E) concentrations and activities of D2 (F) and D3 (G) in muscle of 18-week-old
WT and MAA (Ercc1-/Δ-7) mice (n = 3/group). T4 (H) and T3 (I) concentrations and activities of D2 (J) and D3 (K) in muscle of 26-, 104-, and 130-week-old
WTmice (n = 3-5/group). Values represent mean ± SE per group. * P < 0.05
doi:10.1371/journal.pone.0149941.g006
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[10,12], we investigated if the aging-induced hepatic Dio3 expression (Fig 4D and 4H) is caused
by the suppressed somatotrophic axis. To test this possibility, we first assayed hepatic D3 activ-
ity in 6-month old transgenic mice over-expressing bovine GH (bGH TG mice), which exhibit
shortened lifespan and several features of accelerated aging [18]. Fig 9A suggests that the GH/
IGF1 pathway impinges on liver D3 activity, as this was significantly reduced in bGH TG ani-
mals compared to normal littermates. Consistent with these findings, D1 activity was slightly
but significantly higher in bGH TG than in WTmice (Fig 9B). Next, we determined D1 and
D3 activities in Ghr KOmice as a model for reduced GH/IGF1 signaling. However, overall no
significant changes were detected (Fig 9C and 9D). Thus, activation of the GH/IGF1 pathway
appears to suppress hepatic D3 activity, but interruption of the GH/IGF1 pathway has no effect
on liver D3. Therefore, the re-activation of liver D3 in the different aging mouse models
appears largely independent of the suppressed somatotrophic axis.
WT animals treated with the pro-oxidant DEHP have lowered thyroid
state
Our data from DNA repair deficient animals suggests that accumulating DNA damage some-
how leads to the induction of hepatic and renal D3 activity. This hypothesis was tested using
WT animals chronically exposed to oxidative stress, resulting in increased DNA damage.
Therefore, WT mice were exposed through the diet for 2, 12 or 39 weeks to low levels of bis
(2-ethylhexyl)phthalate (DEHP), which induces oxidative damage among others to DNA. Nei-
ther body or liver weight nor food intake of DEHP-exposed animals differed from untreated
controls (data not shown), indicating that the DEHP levels used were non-toxic. As shown in
Fig 10A, D1 activity was significantly and progressively decreased in DEHP-treated mice. Con-
versely, D3 activity was induced in mice exposed to oxidative stress (Fig 10B) in support of our
hypothesis. These changes are apparently regulated at the transcriptional level since expression
levels of Dio1 were reduced and those of Dio3 were induced (S9 Fig). Both decreased D1 activ-
ity and increased D3 activity presumably contribute to the hypothyroid state of the liver,
reflected by the decreased hepatic Dio1 and Thsrp expression (S9 Fig). These findings provide
Fig 7. Thyroid state in heart of progeroidmice. T3 (A) and T4 (B) concentrations and activities of D2 (C) and D3 (D) in heart of 15-day-old WT and XAA
(Csbm/m/Xpa-/-) mice (n = 3/group). Values represent mean ± SE. * P < 0.05; # P = 0.07
doi:10.1371/journal.pone.0149941.g007
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strong support for the hypothesis that accumulation of DNA damage underlies the suppression
of TH signaling in the different models of premature and normal aging.
Discussion
It has been well recognized that thyroid state changes during aging, but cause and conse-
quences have remained largely elusive [35]. Since TH is one of the major stimulators of metab-
olism, changes in thyroid state may represent an important link between aging and key
alterations in metabolism.
In the present study we used different approaches to investigate TH signaling in different
models of accelerated and normal aging. First, microarray analysis of liver tissue revealed a
common transcriptomic signature between hypothyroid WT mice and mice undergoing
Fig 8. Thyroid state in brains of progeroid and naturally agedmice.Homogenates of whole brain or hemispheres were used. T4 (A) and T3 (B)
concentrations in brains of 7-, 12-, 15-, and 18-day-old WT (squares) and XAA (Csbm/m/Xpa-/-) mice (n = 3/group). Activities of D2 (C) and D3 (D) brains of
7-, 12-, 15-, and 18-day-old WT and XAA (Csbm/m/Xpa-/-) mice (n = 3/group). T4 (E) and T3 (F) concentrations and D3 activity (G) in brains of 4-, and
18-week-old WT (black bars) and MAA (Ercc-/Δ-7) (white bars) mice (n = 3/group). It was not possible to measure D2 activity due to technical constraints.
Values represent mean ± SE per group. * P < 0.05; ** P < 0.01; *** P < 0.001.
doi:10.1371/journal.pone.0149941.g008
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Fig 9. Effects of the changes in the GH/IGF1 axis on deiodinase activities. Activities of D3 (A) and D1 (B) in 2-month-old WT and bGH transgenic mice
and of D3 (C) and D1 (D) in 6-month-old WT and Ghr KOmice. Values represent mean ± SE per group (n = 5–6). * P < 0.01.
doi:10.1371/journal.pone.0149941.g009
Fig 10. Liver D1 and D3 activity in DEHP-treatedWTmice. Activities of D1 (A) and D3 (B) in 10-wk-oldWT animals after exposure or not to subtoxic doses
of the pro-oxidant DEHP for 2, 12 and 39 weeks. Values represent mean ± SE per group (n = 5). * P < 0.05; ** P < 0.01.
doi:10.1371/journal.pone.0149941.g010
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normal or accelerated aging. Similar approaches have previously demonstrated system-wide
similarities between progeroid and normally aging mice [3,4]. Second, we analyzed the expres-
sion of a set of T3-responsive genes, which confirmed that livers from progeroid mutants are in
a hypothyroid state. Third, we assayed hepatic D1 activity which plays a role in the peripheral
conversion of T4 to bioactive T3. D1 is also positively regulated by T3, and regarded as one of
the most specific markers of hepatic thyroid status [36]. In livers from XAA and MAAmice as
well as normally aging mice, D1 activity was suppressed. Altogether, our findings indicate that
liver TH signaling is attenuated in aging animals.
The significant decrease in expression of T3-responsive genes, including Dio1, in livers from
MAAmice, is in contrast with the normal T3 and T4 levels in serum and liver. Several scenar-
ios may explain this paradox. First, actions of TH are mediated by the free TH concentrations,
while measured TH levels reflect total concentrations, mostly bound to carrier proteins. There-
fore, the measured serum total TH concentrations may be an overestimation of the actual avail-
able TH levels. Second, TH in the liver may be sequestered to varying extents in cell
compartments, limiting the availability of the hormone for the nuclear T3-receptor. Third,
downregulation of Thrb in livers from MAAmice can contribute to diminished signaling at
the receptor level. In contrast to liver, renal TH concentrations were decreased in MAA mice,
consistent with the local modulation of effective TH concentrations (Fig 5F). Of note, com-
pared to XAA and normally aging mice, MAA mice show dramatic features of premature
aging specifically in the liver as well as in the kidney. Liver pathology includes early and mas-
sive nuclear polyploidy and invaginations, reduced proliferation, increased apoptosis, and ele-
vated serum levels of liver-specific enzymes, pointing to severe liver pathology [3, 7, 17, 37].
Kidney aging pathology also includes karyomegaly, as well as proteinuria and progression to
end stage renal failure with uremic encephalopathy [38,39]. Additionally gene-expression pro-
files are consistent with accelerated aging [40]. It is possible that the additional defect in inter-
strand cross-link repair in MAA (Ercc1-/Δ-7) mice results in a more pronounced hypothyroid
state in the liver and to a somewhat lesser extent kidney compared to the XAA (Csbm/m/Xpa-/-)
mice which lack the interstrand cross-link repair defect.
Perhaps one of the most intriguing findings in our study is the large induction of liver D3 in
XAA and normally aging mice (Fig 5D, 5H and 5J). Regulation of D3 is complex and differ-
ently regulated among various tissues [13]. Normally, D3 is highly expressed in embryonic tis-
sues and at lower levels in the adult brain, but it is hardly expressed in most other adult tissues
[41]. The induction of liver D3 activity may only be partially explained by the attenuated GH/
IGF1 axis in aging animals. In bGH TG animals, D3 activity was diminished, which is reminis-
cent of studies in which GH administration to chicken embryos acutely repressed D3 activity
with a consequent increase in serum T3 levels [33,34]. Interestingly, bGH TGmice display
enhanced growth but also several features of accelerated aging, including increased cancer sus-
ceptibility, and shortened lifespan [9,42]. However, only minor changes in D3 activity were
observed in Ghr KO animals (Fig 9A and 9C), which is in line with observations of similar
increases in D3 activity induced by caloric restriction in normal and Ghrmutant chicken [43].
Thus, it appears unlikely that the suppressed GH/IGF1 axis in progeroid mice is a major factor
in the stimulation of D3 activity. Also, other factors known to interfere with TH signaling (e.g.
glucocorticoid or adrenergic signaling) are unlikely to cause deiodinase changes in the proger-
oid and normal aging models [5,6]. Recently, several studies have unequivocally demonstrated
that D3 is re-activated in certain pathological situations such as critical illness, ischemic dis-
ease, tumorigenesis, and tissue regeneration [25,44–46]. Consequently, TH inactivation is
increased in these conditions, resulting in lower TH levels. Interestingly, induction of D3 can
affect TH concentrations in a tissue-specific way without impeding thyroid state systemically
[13]. Our results clearly demonstrate that aging is also associated with induction of D3
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expression in particular in liver. It is important to note that this occurs in the absence of obvi-
ous cachexia or illness. Hepatic D3 activity was induced not only in normally and rapidly aging
mice but also in WT mice after chronic exposure to sub-toxic concentrations of the pro-oxi-
dant DEHP, all animal models associated with increased DNA damage. In addition, all models
displayed reduced liver D1 activity. Although submicroscopic abnormalities cannot be
excluded, histological examination of the progeroid thyroid glands was unremarkable. Also,
the pituitary appears unaffected, which is in line with previous reports [3,4]. Thus, changes in
peripheral deiodination, including the increased D3-mediated T3 and T4 inactivation and
decreased D1-mediated T3 production, may contribute to the diminished TH signaling during
aging.
As noted above in the context of Ercc1 mutant mice, also the kidneys appeared in a hypo-
thyroid state in the different models of normal and accelerated aging, although less pronounced
than in the liver. Except for normally aging mice, no induction of D3 was observed. Given the
3-fold lower activity in kidney versus liver, D3 may be less important for local TH signaling in
the kidney.
In contrast to liver and kidney, TH signaling appears not to be changed in heart and skeletal
muscle during aging. If anything, the up-regulation of cardiac D2 in XAA mice, and the down-
regulation of muscle D3 in normally aging mice may even suggest preserved TH signaling in
these tissues. Indeed, muscle and liver show a divergent response in TH signaling during illness
[47]. In both mutant models, no change in TSH was observed, which might reflect a relative
insensitivity of the pituitary gland towards TH. However, in WT aging animals we noticed a
small but significant increase in TSH levels in the pituitary at 130 weeks of age. This supports
the idea that aging brings about a lowering of thyroid state.
Also in brain TH signaling appears to be preserved. Although TH levels and deiodinase
activities were measured in whole brain, while TH homeostasis may be controlled in a region-
specific manner, our findings do not support the idea of a global decrease in TH signaling in
the aging brain. In fact, the observation that the T3/T4 ratio tended to increase in the brain,
rather than to decrease as in the liver, is compatible with the maintenance of vital brain func-
tions during aging. This is also suggested by the observation that brain weight is clearly less
decreased than total body, liver and kidney weight in XAA mice. Interestingly, in various spe-
cies caloric restriction results in larger reductions in liver weight than in brain weight [48,49].
Thus, progeroid mutants appear to reallocate resources and metabolism to spare the most vital
organs, suggesting that preserved functional brain capacity is beneficial for survival.
All aspects of TH signaling showed similar trends in normally vs. rapidly aging mice. The
most prominent changes were noted in XAA mice the most severe progeroid model in our
studies. This is conceivable as lifespan is dramatically reduced in these animals (3–5 weeks)
compared to WT mice and even MAAmice (up to 6 months). Therefore, the severity of the
progeroid phenotype may correlate with the degree of the TH response to aging [2,3,5].
Although changes were less pronounced in normally aging animals, the strong similarities with
changes observed in the progeroid mice indicate that the latter provide good models for normal
aging. DNA damage may induce different responses in different tissues, because of varying effi-
cacies of mechanisms to induce, prevent or repair such damage, which may explain differences
between the different models of normal and advanced aging examined. Nevertheless, our find-
ings suggest that a common mechanism affects the cellular deiodinase activities in normal and
premature aging. Future studies in mouse models with other DNA repair defects will establish
if the present findings are universal.
What is the relevance of attenuated TH signaling during aging? Previous investigations
have reported reduced GH/IGF1 signaling during aging [2–4]. Because suppression of the
somatotrophic axis is also observed in stress situations such as calorie restriction or disease, it
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is argued that the consequent reduction in growth and metabolism (and up-regulation of
defense mechanisms including the anti-oxidant system) reflects an attempt to survive stressful
conditions [5]. This suppression of the GH/IGF1 axis may be regarded as an adaptive ‘survival’
response which is triggered also during DNA damage accumulation and the aging process [5].
At present, the exact underlying molecular mechanisms which initiate this trigger are
Fig 11. Schematic representation of the survival response. Several types of stress (e.g. DNA damage and aging) can trigger a differential response in
various tissues. This response ensures decreased TH signalling in liver and kidney, while it preserves TH signalling in brain, muscle and heart.
doi:10.1371/journal.pone.0149941.g011
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unknown. Our observations are reminiscent of changes in thyroid state during periods of stress
[50]. Dwarf mice with pituitary malfunction resulting in lower GH, IGF1 and TH concentra-
tions also have a prolonged lifespan, whereas life-long T4 substitution of these animals
markedly shortens their lifespan [14–16]. Thus, moderate hypothyroidism may prolong life-
span in mice [51]. These observations suggest that a global reduction in TH-driven metabolism
functions as a protective mechanism to survive a stressful period (Fig 11). Apparently, less vital
organs (liver, kidney) benefit from decreased TH signaling, while in other organs (brain, mus-
cle, heart) it is essential to maintain normal TH metabolism. Thus, attenuated TH signaling in
liver and kidney likely represents part of a protective survival response elicited in normal and
in premature aging due to defective DNA repair, which is highly tissue-specific.
What is the relevance of our findings for humans? Several reports suggest that subclinical
hypothyroidism in elderly people is associated with increased lifespan [52,53]. Furthermore,
genetic predisposition for a subtle decrease in thyroid function is associated with increased lon-
gevity in centenarians and their offspring [54,55]. In addition, several studies suggest that sub-
clinical hypothyroidism provides some functional advantage in daily living tasks [53,56]. This
may have important clinical implications for the decision whether or not to treat elderly
patients with mild hypothyroidism. Our results suggest that the decreased thyroid state during
aging is an adaptive response, providing a mechanistic basis for the epidemiological observa-
tions in humans. Future studies should explore further underlying mechanisms as well as gen-
der differences (which was not assessed in the present study) in the response to DNA damage.
Until now, the molecular relationship between DNA damage, aging and changes in thyroid
state were elusive. The present study for the first time provides evidence that DNA damage may
contribute to the attenuated TH signaling during aging. In addition, we discovered a novel role
of D3 during the aging process. We propose that the tissue-specific regulation of deiodinase
activities resulting in decreased TH signaling in particular tissues importantly contributes to the
adaptive survival response during aging both at the systemic and organ-specific level. This
response likely aims to minimize further damage by an evolutionary strongly selected reduction
and redesign of metabolism and shift from growth and proliferation to a preservation mode.
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